Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#ChineseJournalOfHematology

Home » #ChineseJournalOfHematology
Application of high-throughput next-generation sequencing in diagnosis and treatment of myeloid hematologic malignancies in the era of precision medic

Application of high-throughput next-generation sequencing in diagnosis and treatment of myeloid hematologic malignancies in the era of precision medic

Posted by By Mourabit Halima 2024.01.18
In May 2023, Professor Jun Ma and his team from Harbin Institute of Hematology Oncology published a paper in the Journal of Leukemia & Lymphoma titled "Application of high-throughput next-generation…
Read More
🩸🇨🇳💡Current status of diagnosis and treatment of chronic lymphocytic leukemia in China: A national multicenter survey research

🩸🇨🇳💡Current status of diagnosis and treatment of chronic lymphocytic leukemia in China: A national multicenter survey research

Posted by By Mourabit Halima 2024.01.18
Professor Jun Ma and his team from Harbin Institute of Hematology Oncology published in May 2023 in the Chinese Journal of Hematology titled "Current status of diagnosis and treatment of…
Read More
Recent Posts
  • CSCO BC 10th Anniversary Tribute | President Jinming Yu: A Decade of Growth and Remarkable Achievement — Looking Forward to CSCO BC Continuing to Shape a New Vision for Cancer Prevention and Care While Amplifying China’s Voice
  • CSCO BC Guidelines & Consensus | Professor Qiang Liu: Interpreting the Chinese Expert Consensus on the Diagnosis and Treatment of Young Breast Cancer (2025 Edition) — Optimizing Risk Stratification and Full-Cycle Management for Young Patients
  • CSCO BC Guideline Highlights | Professor Man Li: Focusing on HER2-Low and HER2-Ultralow Breast Cancer — Key Updates and Practical Changes in the 2026 Guidelines
  • CSCO BC Guideline Highlights | Professor Shusen Wang: Key Updates in Advanced Triple-Negative Breast Cancer Management — From Salvage Chemotherapy to a New Era of Immunotherapy-Based Combination Strategies
  • Nature Communications Publishes Breakthrough Study Led by Academician Xu Binghe and Collaborators: China-Developed AKT Inhibitor Delivers Promising First-in-Human Results
Recent Comments
    Archives
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top